Skip to content

Patients › Rehabilitation

屈肌腱鞘腱鞘囊肿切除术

在手指近端切除屈肌腱鞘囊肿(掌侧支持带囊肿)后,快速、以运动为导向的康复计划:在开始轻柔的手指活动(数日内)的同时保护小的手掌伤口,随后随着伤口愈合,逐步加入瘢痕护理和抓握训练。

掌侧指根部小硬结囊肿示意图,起源于A1滑车处的屈肌腱鞘。
屈肌腱鞘囊肿(掌侧支持带囊肿)是位于手指根部掌侧的一个小而坚硬的肿块,起源于腱鞘;切除术会移除囊肿及一小圈腱鞘。 Kieran Hirpara 4.0

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

本方案指导您在 Mater Private Hospital Rockhampton 接受 Kieran Hirpara 医生进行的小手术(切除屈肌腱鞘囊肿)后的康复。该囊肿是位于手掌侧手指根部的一种坚硬囊肿。方案首先介绍您的居家锻炼计划,随后是专为您的手部治疗师编写的结构化临床方案;请在首次治疗就诊时携带此页面或其 PDF 文件,以确保您的康复过程协调一致。您的手部治疗师可能会根据您的康复进展调整计划。

如果您对术后伤口有任何疑虑,请联系前台。通常,拍摄伤口照片并通过电子邮件发送以供审阅会很有帮助。

预期情况

屈肌腱鞘囊肿(又称掌侧腱鞘囊肿)是一种小而坚硬、常有压痛的肿块,通常直径仅几毫米,生长于屈肌腱穿行的腱鞘内,位于手指掌侧基部(常见于被称为A1滑轮的坚韧带状结构上,即手指与手掌交界处的褶皱处)。该肿块固定于腱鞘,屈曲手指时不会移动。这是一种完全良性(非癌性)的肿块,也是手部和腕部较常见的腱鞘囊肿之一。

手术为小型日间门诊切除术。Hirpara医生通过手掌上的短锯齿状切口,将囊肿连同其起源的腱鞘一小部分袖口状组织一并切除。沿手指两侧走行的两条小神经和血管会被仔细保护。腱鞘本身不予修复:保持其开放是有意为之,并不会削弱手指功能。皮肤以缝合线关闭。

由于愈合过程中无需保护手指内部结构,因此恢复迅速:以周计,而非以月计。方案很简单:保护手掌小伤口,控制肿胀,并在数天内开始轻柔的手指活动,以防止手指僵硬及肌腱粘连至愈合中的瘢痕。伤口愈合后,通过瘢痕按摩和脱敏处理使该区域恢复平静,并逐步重建握力。早期伤口周围可能出现轻微麻木或压痛,这是小皮神经恢复的常见现象,通常会在随后的几周内消退。

注意事项与限制

  • 在伤口愈合且拆线之前(通常为术后第 10–14 天左右),请保持敷料清洁干燥。通常没有石膏,也一般不使用夹板,仅使用软敷料。
  • 请在术后最初几天内开始轻柔的手指活动(弯曲、伸直及肌腱滑动),以防止僵硬和肌腱粘连。
  • 请保持手部抬高,并在舒适范围内用于轻度的日常活动。
  • 在伤口稳定之前(大约两到三周),切勿进行重度抓握、提重物或用力捏取。
  • 在伤口完全愈合之前,切勿按摩疤痕或浸泡手部。
  • 在敷料妨碍您安全握持方向盘期间(通常约为术后第一周),切勿驾驶车辆。

关于伤口、肿胀及疤痕管理,请参阅本诊所的伤口护理指南。

您的练习

缓慢地轻柔握拳,然后将所有手指完全伸直。

Kieran Hirpara 4.0

手指活动(轻柔握拳并伸直)

在最初几天内,轻轻握成柔软的拳头,然后将手指完全伸直,动作要缓慢,且仅在舒适范围内进行。早期活动可防止手指僵硬,并阻止肌腱粘连于愈合中的伤口。切勿强行用力——请以敷料和轻微不适感作为指导。

10次,3–4 次/天,以舒适为度

手指沿腱滑动位移动:钩状位(爪形)、完全握拳位及平直伸直位。

Kieran Hirpara 4.0

腱滑动(钩状、握拳、伸直)

将手指依次做三种形态:钩状(弯曲指尖及中间关节,但保持掌指关节伸直,形似爪状)、完全握拳,以及平直伸展的手。这些体位可使屈肌腱在手术区域滑动,从而保持其自由滑动而不发生粘连。每个动作请保持轻柔且无痛。

每个姿势5次,每天3–4次

将手举至高于心脏水平,并轻柔地活动手指。

Kieran Hirpara 4.0

肿胀控制

在术后第一周,请尽可能将手抬高至心脏水平以上,并轻柔地屈伸手指以泵出肿胀。肿胀越少,手指越轻松舒适,恢复也越顺畅。早期手掌周围出现轻微肿胀属于正常现象。

白天经常抬高患肢;清醒时每隔约一小时进行轻柔的手指屈伸运动

用指尖按摩已愈合的掌部瘢痕,并以不同质地摩擦该瘢痕,以稳定其敏感性。

Kieran Hirpara 4.0

瘢痕按摩与脱敏

待伤口完全愈合且拆线后(通常约两周),用指腹以小而有力的圆圈动作在疤痕上涂抹少量润肤霜,持续数分钟,随后用不同质地的物品(先软布,后毛巾)轻抚该区域。此操作可软化疤痕,并缓解初期因细小皮肤神经恢复而常见的触痛和刺痛感。切勿按摩开放或未愈合的伤口。

每天2–3次,每次几分钟,待完全愈合后

在手掌中挤压软球或橡皮泥以增强握力。

Kieran Hirpara 4.0

握力强化

后期练习——从术后约两到三周开始,待伤口稳定且您的手部治疗师确认无碍后进行。轻轻挤压软球或治疗用橡皮泥,保持数秒,然后放松,并逐渐增加力度。此练习旨在重建抓握力,为完全使用手部做准备。若伤口处出现剧烈疼痛,请立即停止。

10–15 挤压,每天 2–3 次(从约 2–3 周开始)

这些是您手册中的练习。仅在Hirpara医生和手部治疗师的指导下开始进行,并严格保持在您被设定的限制范围内。早期练习(轻柔的握拳与伸直、肌腱滑动及肿胀控制)从术后最初几天起就能保持手指活动并促进肌腱在内部滑动,这是实现顺利康复的最重要事项。瘢痕按摩和脱敏训练在伤口完全愈合后开始,而握力强化则属于稍晚的阶段(大约从术后两到三周开始)。任何导致伤口处剧烈疼痛的动作都应立即停止。

您的临床方案

本页其余部分为切除屈肌腱鞘囊肿(掌侧腱鞘囊肿)后的分阶段康复临床方案。本节内容应提供给您的手部治疗师,每个阶段均以通俗易懂的语言解释正在发生的情况。这是一项切除术,而非修复术:腱鞘保持开放状态,没有需要保护的修复结构。该方案是一条早期活动路径,围绕伤口保护、水肿控制、防止粘连的腱滑动以及瘢痕/脱敏训练构建,而非保护性固定。

在治疗前,请查阅手术报告及既往病史,并与主刀医生沟通涉及的手指、腱鞘切除范围以及指部神经血管束的完整性。Hirpara 医生的切除术采用 A1/近端腱鞘上方的 Bruner(锯齿形)掌侧切口,连同腱鞘袖状组织一并切除囊肿;腱鞘不予修复,除软敷料外无其他固定。指部神经暂时性感觉异常常见且可自行缓解。

第一阶段 — 伤口保护与早期活动(第 0 周至约第 1 周)

第一周旨在保护小的手掌伤口,并让手指早期活动,以防止僵硬或形成肌腱粘连。手部采用无夹板的厚软敷料进行管理,保持抬高,并在数天内开始轻柔的主动手指活动。

致您的手部治疗师:

教育与注意事项 - 仅使用厚软敷料,不使用夹板;保持清洁干燥直至拆线(约第 10–14 天) - 保护伤口免受重负荷;在舒适范围内进行轻度的无负荷手部使用 - 告知患者,伤口周围出现暂时性的指神经感觉异常/感觉过敏是常见的,且会自行缓解

管理 - 伤口:按指示使用外科敷料;监测感染迹象 - 水肿:抬高至心脏水平以上,进行轻柔的手指泵动,必要时冰敷 - 练习:数天内开始轻柔的主动手指主动活动范围(AROM)(轻柔的整体握拳和完全伸展)以及肌腱滑动(钩状/拳状/伸直);未受累手指、拇指和腕关节的主动活动;轻度功能性使用

进展标准 - 伤口趋于稳定,无感染;早期主动活动范围舒适;随着伤口允许,准备好进行完全主动/轻柔被动活动

第二阶段 — 全范围活动、水肿及瘢痕处理(约第1至3周)

从大约一周开始,活动度逐渐进展至全主动及轻柔被动活动范围(完全握拳及完全伸直),且一旦伤口完全愈合且拆线后,即开始瘢痕按摩及脱敏治疗。水肿控制持续进行。

致您的手部治疗师:

评估 - 主动及被动手指活动范围(目标为完全握拳及完全伸直);伤口/瘢痕状况;肿胀;指神经敏感性

宣教及注意事项 - 在舒适度允许的情况下,进展至全主动及轻柔被动手指活动 - 仅在伤口完全愈合后开始瘢痕按摩及脱敏治疗 - 在伤口稳定前,避免用力抓握及强力捏持

管理 - 练习:完全复合握拳及完全伸直;继续肌腱滑动练习;对任何残留紧张进行轻柔被动牵伸 - 瘢痕:愈合后行瘢痕按摩 + 纹理脱敏;按需进行水肿管理

进展标准 - 全范围、无痛的主动活动;伤口愈合;瘢痕趋于稳定;准备进行负重

第三阶段——强化与恢复(约第3至6周)

一旦伤口愈合且活动度完全恢复(约三周时),抓握与捏握强化训练即开始进行,并逐步增加负荷,直至完全无限制使用。大多数患者在约四至六周时恢复全部活动,并在约两个月时进行常规随访。

致您的手部治疗师:

评估 - 与健侧对比的抓握与捏握力量;残余瘢痕压痛或感觉异常;功能性/任务特异性需求

宣教与注意事项 - 伤口稳定后,从约 2–3 周开始进行抓握与捏握强化训练;逐步增加负荷 - 随着舒适度与力量的允许,过渡至完全无限制使用

管理 - 练习:橡皮泥/软球抓握挤压、捏握强化、渐进性功能性负荷;继续处理残余瘢痕及脱敏训练 - 当活动度完全恢复,且抓握舒适、接近对称时予以出院;约2个月时进行常规外科随访 - 若恢复停滞、瘢痕持续明显高敏感,或存在复发担忧,请转回主治医生处

完全恢复标准 - 活动度完全且无痛;抓握与捏握舒适;瘢痕稳定;能够满足工作及活动需求

恢复工作与活动

鼓励从初期开始进行轻度日常手部使用(如进食、书写、轻度自我护理),以舒适为限,只要不涉及通过伤口进行重度抓握或强行捏合。大多数人可在数天内完成日常事务。驾驶通常从约一周后恢复,前提是您能够舒适地抓握并控制方向盘,且不再受敷料限制,并需在复诊时经Hirpara医生确认。

抓握和强化训练通常在伤口稳定后,即约两至三周时开始,并逐步加强。完全无限制的活动通常在约四至六周时达到。办公室工作通常可在数天至一周内恢复;较重的体力工作则遵循与抓握功能恢复相同的阶段性进程。通常会在约两个月时安排常规随访。

您的方案之后

本方案与本诊所的一般康复建议配合使用:请参阅术后疼痛管理、伤口护理和疤痕管理。由于该腱鞘囊肿位于手指基部的A1滑车上方,其康复过程与其他掌侧手指基部小手术(如扳机指松解术)有许多共同之处。上述分阶段计划反映了腱鞘囊肿切除术后已发表的指南,您的持续康复将由Hirpara医生和您的手部治疗师根据您手指的进展情况个体化指导。


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Flexor Sheath Ganglion Excision — Lesion, Procedure Outcomes & Post-operative Rehabilitation (Volar Retinacular Cyst)

Topic scope: post-operative rehabilitation after surgical excision of a flexor tendon sheath ganglion (volar retinacular cyst / "seed" ganglion) at the base of a finger — a small, firm, often tender cyst arising from the flexor sheath, commonly over the A1 pulley at the metacarpophalangeal crease of the middle or ring finger. This is an excision, not a reconstruction: the cyst is removed with a small cuff of sheath, the sheath is not repaired, and there is no construct to protect — so the rehab is a brief early-motion pathway built around wound protection, oedema control, tendon gliding and scar/desensitisation work rather than months of protected healing.

Defining principle of the rehab here: a flexor sheath ganglion is a benign cyst tethered to the tendon sheath; excising it (with a cuff of sheath) removes the lesion without creating anything that needs to heal under protection. The sheath is meant to be left open — partial sheath excision does not weaken the digit or cause bowstringing at this level — so immediate, unrestricted light use and early gentle finger motion are the default. The therapy programme exists to keep the flexor tendons gliding through the healing palm wound so they do not adhere, to settle the transient digital-nerve hypersensitivity that commonly follows dissection between the neurovascular bundles, and to mature the scar — not to immobilise. The single branch point is wound healing: scar massage and grip loading wait until the wound is healed and sutures are out.


A. PROCEDURE OUTCOMES (excision of flexor sheath ganglion)

Excision of a flexor sheath ganglion is a small, reliable day-case hand operation: the great majority of patients are rendered symptom-free with a low recurrence rate, and the principal trade-off is the common but self-limiting transient digital-nerve paraesthesia from dissecting the cyst out from between the digital neurovascular bundles.

  • Flexor sheath (volar retinacular) ganglions are a well-defined, common entity. They account for roughly 5–16% of ganglions of the hand and wrist, presenting as a small (typically 3–8 mm), firm, often tender nodule fixed to the flexor sheath at the digit base — classically over the A1/A2 pulley region — that does not move with the tendon [JAAOS 2022; JAAOS 1999; Hand Clin 2004]. Well-established (lesion nature).
  • Surgical excision gives reliable symptom relief with low recurrence. Level-IV case series of flexor sheath / volar retinacular ganglion excision report durable resolution and low recurrence after complete excision of the cyst with a cuff of sheath; recurrence is the main long-term concern and is uncommon when the lesion and its sheath origin are fully removed [Hand 2007; J Hand Surg series; PMC surgical series]. Moderate (level-IV case series).
  • Transient digital-nerve paraesthesia is the principal complication. Because the cyst sits immediately deep to, and is dissected free from, the digital nerves, temporary numbness or tingling in the finger is the commonest reported post-operative event; it is typically self-limiting and settles over weeks. True nerve injury is rare with careful protection of both bundles [Hand 2007; volar retinacular series; Medscape]. Moderate (case series + expert review).
  • Partial excision of the sheath is biomechanically tolerated. Removing the cyst with a small cuff of the flexor sheath at the A1 level does not produce clinically significant bowstringing or weakness, which is the anatomical basis for not repairing the sheath and for an early-motion rehab without protected immobilisation [Hand Clin 2004 (palmar digital ganglia / A1–A2 origin)]. Mechanistic.

B. REHABILITATION / THERAPY EVIDENCE

There are no randomised rehab trials specific to flexor sheath ganglion excision; the post-operative programme is low-level / expert-consensus, but it is strikingly consistent across hand-therapy and surgical sources: dressing only (no splint), early gentle finger motion within days, tendon gliding to prevent adhesion, scar massage and desensitisation once healed, and return to full use by ~4–6 weeks.

  • Dressing-only, no routine splinting. Aftercare guidance for ganglion (including flexor sheath) excision describes a soft dressing with no immobilisation, with the patient encouraged to move the finger early — there is no construct to protect, so splinting is not required and would risk stiffness [MSA aftercare; Medscape]. Weak / consensus.
  • Early active finger motion and tendon gliding prevent stiffness and adhesion. Starting gentle active fist/extension and tendon glides within the first few days keeps the flexor tendons gliding through the palm wound so they do not adhere to the healing scar — the same adhesion-prevention rationale that underpins early-motion hand rehab generally. The benefit is mechanistic / consensus rather than trial-proven for this lesion [hand-therapy aftercare sources]. Weak (mechanism sound).
  • Scar massage and desensitisation, started once healed, settle the wound and digital-nerve hypersensitivity. Palm scars at the digit base are prone to tenderness, and the transient digital-nerve paraesthesia from the dissection responds to graded desensitisation; both begin only after the wound is fully healed and sutures are out (~day 10–14) [MSA aftercare; Medscape]. Weak / consensus.
  • Grip loading and full return are early. Because nothing is repaired, gripping and strengthening begin once the wound has settled (~2–3 weeks) and full unrestricted use is typically reached by ~4–6 weeks, with routine follow-up around two months — consistent across aftercare sources [MSA aftercare; PMC series; Medscape]. Weak / consensus.

Recovery trajectory (expected, evidence-anchored)

Phase Window Restraint Hand use / therapy focus Strength / load Notes
I — Wound protection & early motion Week 0–1 Soft dressing, no splint Elevate above heart; gentle active fist + full extension and tendon glides within a few days; protect wound; light functional use Light unloaded use only Transient digital-nerve tingling is expected, not a complication
II — Full motion, oedema & scar work Week ~1–3 Heavy-grip avoidance Progress to full active + gentle passive motion (full fist, full extension); scar massage + desensitisation once wound healed; oedema control No forceful gripping/pinching until wound settled Sutures out ~day 10–14; scar work only after full healing
III — Strengthening & return Week ~3–6 Restrictions lifted Progress grip/pinch loading; task-specific use Grip/pinch strengthening from ~2–3 wk; full unrestricted use by ~4–6 wk Routine follow-up ~2 months; driving ~1 wk once gripping the wheel comfortably (surgeon discretion)

(Phase windows mirror the precautions and return milestones in the patient protocol; they are typical guides, not trial-derived deadlines.)


C. KEY CONTROVERSIES / EVIDENCE QUALITY

  1. Lesion nature is well-established. The flexor sheath / volar retinacular ganglion is a recognised, characterised entity (firm, sheath-tethered, A1-pulley region, 5–16% of hand/wrist ganglions); its diagnosis and origin are not in dispute. Strong (descriptive).
  2. Excision outcomes are good but evidenced at level IV. Low recurrence and reliable symptom relief come from case series, not controlled trials — adequate for a small benign lesion, but the evidence tier is modest. Moderate (level-IV).
  3. Transient digital-nerve paraesthesia vs true nerve injury. Temporary tingling is common and self-limiting; framing it for patients up front avoids alarm, while careful intra-operative protection of both neurovascular bundles keeps true injury rare. Moderate.
  4. The rehab protocol is consensus, not trial-derived. No RCTs govern post-excision therapy; the dressing-only, early-motion, scar-care, ~4–6-week-return pathway is consistent across sources but rests on expert consensus and the general principles of early-motion hand rehab. Weak / consensus.
  5. Recurrence is the main long-term failure mode and is uncommon after complete excision of the cyst with its sheath origin; a residual or recurrent lump warrants reassessment rather than prolonged therapy. Moderate.

D. EVIDENCE STRENGTH FLAGS (summary)

  • WELL-ESTABLISHED (descriptive): the nature, location and prevalence (5–16% of hand/wrist ganglions) of flexor sheath / volar retinacular ganglions.
  • MODERATE (level-IV case series): reliable symptom relief and low recurrence after excision; transient digital-nerve paraesthesia as the principal, self-limiting complication; recurrence as the main long-term failure mode.
  • WEAK / CONSENSUS: the dressing-only, early-motion, scar-care rehab programme and its phase timings (consistent across aftercare sources, mechanistically rationalised, but not trial-derived); ~4–6-week full return and ~1-week driving (surgeon discretion).

CITATIONS

RAG corpus (180,000+ Orthopaedic articles)

  • Ganglions of the hand and wrist. J Am Acad Orthop Surg. 2022. DOI: 10.5435/jaaos-d-22-00105
  • Ganglions of the hand and wrist. J Am Acad Orthop Surg. 1999. DOI: 10.5435/00124635-199907000-00003
  • Surgical excision of flexor sheath ganglions of the hand: results and outcomes. Hand (N Y). 2007. DOI: 10.1007/s11552-007-9028-4
  • Volar retinacular ganglions of the hand: a clinical series. J Hand Surg Am. 2011. DOI: 10.1016/j.jhsa.2011.05.013
  • Palmar digital ganglia and the A1–A2 sheath origin. Hand Clin. 2004. DOI: 10.1016/j.hcl.2004.03.015

Flexor sheath ganglion / rehabilitation literature (URLs)

  • Surgical excision of flexor sheath ganglions — case series (full text). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC2527143/
  • Volar retinacular ganglions of the hand. Journal of Hand Surgery (American). https://www.jhandsurg.org/article/S0363-5023(11)00627-7/abstract
  • Ganglion cyst excision — post-operative aftercare (dressing-only, early motion, scar care, ~4–6 week return). Mississippi Sports & Arthritis (MSA) Hand Center. https://msapc.com/hand-center/aftercare/ganglion-cyst-excision/
  • Ganglion treatment (surgical excision, recurrence and transient digital-nerve paraesthesia). Medscape. https://emedicine.medscape.com/article/1243525-treatment

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.